(Q38000198)

26 August 2017

1 reference

title

Gallstone dissolution. (English)

1 reference

26 August 2017

Talamini MA

1

1 reference

26 August 2017

Gadacz TR

series ordinal

2

1 reference

26 August 2017

publication date

1 December 1990

1 reference

Surgical Clinics of North America

26 August 2017

published in

1 reference

26 August 2017

volume

70

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

1217-1230

1 reference

Cholelitholysis using methyl tertiary butyl ether

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Analysis of response to ursodeoxycholic acid for gallstone dissolution

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

The value of radiology in predicting gallstone type when selecting patients for medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Risk factors for the development of cholelithiasis in man (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Infusion therapy of choledocholithiasis: technique for catheter placement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Identification of patients with cholesterol or pigment gallstones by discriminant analysis of radiographic features

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Clinical experience with monooctanoin for dissolution of bile duct stones:" an uncontrolled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Alternating treatment of common bile duct stones with a modified glyceryl-1-monooctanoate preparation and a bile acid-EDTA solution by nasobiliary tube.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Retained biliary tract stones. Nonsurgical treatment with capmul 8210, a new cholesterol gallstone dissolution agent

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

The National Cooperative Gallstone Study Report: A Surgeon's Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Systemic side effects from the intrabiliary infusion of monooctanoin for the dissolution of gallstones

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Ursodeoxycholic acid for the dissolution of radiolucent gall bladder stones

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Increased risk of cholelithiasis with prolonged total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Resident research award. Effects of cholecystokinin on gallbladder stasis and cholesterol gallstone formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Selection of patients for dissolution of retained common duct stones with mono-octanoin.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

In vitro dissolution of gallstones: comparison of monooctanoin, sodium dehydrocholate, heparin, and saline

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Efficacy and Specificity of Chenodeoxycholic Acid Therapy for Dissolving Gallstones

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Pigment vs cholesterol cholelithiasis: Clinical and epidemiological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Dissolution of cholesterol ductal stones in the biliary tree with medium-chain glycerides

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Treatment of retained common bile duct stones: a prospective controlled study comparing monooctanoin and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2816%2945280-1

7 January 2021

10.1016/S0039-6109(16)45280-1

Identifiers

DOI

0 references

1 reference